Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer: Concordance With the "Standard" Testing Method From Tumor Tissue and Review of Associated Timelines and Costs

NCT02502656 is registered in ClinicalTrials.gov with Association des Gastroentérologues Oncologues as lead sponsor.

NCT NCT02502656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02502656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer: Concordance With the "Standard" Testing Method From Tumor Tissue and Review of Associated Timelines and Costs
Lead sponsor
Association des Gastroentérologues Oncologues
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2015
Completion date
August 31, 2017
Enrollment
425 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer